GENE ONLINE|News &
Opinion
Blog

2017-08-07|

“Project Oxygen”of Precision Medicine Exclusive Interview of Dr. Chris Tsai, Founder of Bionet

by GeneOnline
Share To
The U.S. Food and Drug Administration allowed 23andMe to directly sell genetic testing those provides information on an individual’s genetic predisposition to certain medical disease or conditions in April this year. The approval become a milestone in the field of genetic testing. The development of genetic testing leads to an information explosion. Many people may question: "Is these information just for a one time use? Can the results be reused in the future?" GeneOnline interviewed Dr. Chris Tsai, founder of Bionet, to share how he assembled the core technology of Bionet and GGA. Bionet is a company aiming to provide everyone from youngers to seniors with a better life quality by integrating and reusing medical big data.

It's free! Log in now to read

LATEST
GSK’s Blenrep Scores World-First Approval in UK for Multiple Myeloma
2025-04-17
Exosomes: The Small Couriers Moving Beyond Traditional Drug Delivery
2025-04-17
Trump Administration’s CDC Layoffs Shutter STD Lab, Sending Ripples Through Biotech and Global Health
2025-04-17
Fake Ozempic Floods Market as FDA Warns Patients to Check Authenticity of Prescriptions
2025-04-16
NIH Facing $20 Billion Budget Cut and Potential Consolidation in 2026
2025-04-16
Trump Administration Budget Proposal Includes $20 Billion Cut to NIH by 2026 and Agency Reorganization
2025-04-16
Robert F. Kennedy Jr.’s Proposed Budget Prioritizes Public Health, Environmental Protection, and Healthcare Reform
2025-04-16
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
Scroll to Top